Ethereum Price Forecast and Analysis – September 14, 2017

ETH prices fell roughly 11.36% in the last 24 hours to near $238.72. At the same time, the Ethereum to Bitcoin exchange rate dropped almost 5.44%.

The biggest piece of Ethereum news today is the potential Chinese crackdown on cryptocurrency exchanges. Well, that and the recent comments from Jamie Dimon, CEO of JPMorgan Chase & Co. (NYSE:JPM).

Both of these developments dragged down the short-run Ethereum price.

The post Ethereum Price Forecast and Analysis – September 14, 2017 appeared first on Profit Confidential.

See original here:
Ethereum Price Forecast and Analysis – September 14, 2017

Ripple Price Forecast and Analysis – September 14, 2017

XRP prices took a tumble in the last 24 hours, falling below the $0.20 handle as fears of a Chinese crackdown solidified. The Ripple to USD exchange rate fell roughly 3.58%, while the Ripple to Bitcoin rate only edged down by around 0.08%.

Most of the pessimism was drawn from China’s potential closure of cryptocurrency exchanges.

Here’s a rough sketch of what we know and when we knew it.

Last week, there were rumors that the government was.

The post Ripple Price Forecast and Analysis – September 14, 2017 appeared first on Profit Confidential.

Read the original post:
Ripple Price Forecast and Analysis – September 14, 2017

Litecoin Price Forecast and Analysis – September 14, 2017

In an unexpected twist, today’s Litecoin news revolves around Jamie Dimon, CEO of JPMorgan Chase & Co. (NYSE:JPM), and an obscure Chinese think tank called China’s National Internet Finance Association (NIFA).

Let’s start with Wall Street’s poster boy.

While speaking at a conference in New York, Dimon claimed that Bitcoin “is a fraud” and will blow up before long. “It’s worse than tulip bulbs,” he said, in reference to the famous asset bubble from the 1600s.

Dimon claimed that there would be significant losses for anyone “stupid” enough to trade cryptocurrencies. (Source: ".

The post Litecoin Price Forecast and Analysis – September 14, 2017 appeared first on Profit Confidential.

Continue reading here:
Litecoin Price Forecast and Analysis – September 14, 2017

Sleepless Nights Do No Favors for Your Heart – Anti Aging News

Poor sleep won't simply leave you bleary-eyed. It's also linked with stroke and reduced blood supply to the heart, a new study suggests."Poor sleep" includes too short or too long sleep, difficulty falling asleep and difficulty maintaining sleep, said lead researcher Dr. Nobuo Sasaki.

(HealthDay News) -- Poor sleep won't simply leave you bleary-eyed. It's also linked with stroke and reduced blood supply to the heart, a new study suggests.

"Poor sleep" includes too short or too long sleep, difficulty falling asleep and difficulty maintaining sleep, said lead researcher Dr. Nobuo Sasaki.

"Poor sleep is associated with cardiovascular diseases ... but the kind of sleep disturbances that are most risky is not well documented," said Sasaki, of the Hiroshima Atomic Bomb Casualty Council in Japan.

The researchers set out to investigate sleep problems linked to heart attack and angina (coronary artery disease), and stroke.

Coronary artery disease is caused by narrowed heart arteries. This means less blood and oxygen reach the heart, raising the risk for heart attack and chest pain known as angina, according to the American Heart Association.

The observational study involved nearly 13,000 men and women living in Hiroshima. These people, average age 68, were registered for a yearly health check. Close to 800 had a history of heart attack, angina or other conditions associated with reduced blood flow to the heart. The researchers said 560 had a history of stroke, and about 11,500 had no evidence of heart disease.

The volunteers filled out a questionnaire about their sleep habits. Seven possible sleep scores ranged from mild personal views of poor sleep quality to sleep loss that interferes with normal daytime functioning. The higher the score, the worse the participants' sleep quality, the study authors noted.

Among the patients with prior coronary artery disease, 52 percent experienced poor sleep. The same was true for 48 percent of stroke survivors and just 37 percent of those with no history of artery disease, the findings showed.

The study doesn't show a direct causal relationship. Still, the results "support the hypothesis that sleep deterioration may lead to cardiovascular disease," Sasaki said in a news release from the European Society of Cardiology.

Once the researchers took other possible contributing factors into account, they found a significant link between poor sleep and coronary artery disease.

Waking up during the night, not sleeping enough and daytime fatigue were all associated with reduced blood flow to the heart. Trouble falling asleep and reliance on sleeping pills were linked to both coronary artery disease and stroke, the study found.

"The proportion of people suffering from sleep disturbances is around 1.5-fold higher among patients with previous [coronary artery disease] or stroke compared to those with no history of cardiovascular disease," Sasaki said.

"Interestingly, only patients with [coronary artery disease] reported difficulty maintaining sleep and short sleep duration," he added. "Difficulty maintaining sleep reflects an increase in sleep fragmentation, which refers to brief moments of waking up." He said this causes overactivity of the sympathetic nervous system and adrenocortical axis, which is the body's stress response system.

The study findings were presented Tuesday at the annual meeting of the European Society of Cardiology in Barcelona, Spain. The findings should be considered preliminary until published in a peer-reviewed medical journal.

The moral of the story is sleep is good. Most people need more sleep. Anytime an article promotes common sense as it relates to your health the American Academy of Anti-aging Medicine supports such advice, Dr. Ronald Klatz, President of the A4M.

More information

The U.S. National Heart, Lung, and Blood Institute has more on the health effects ofsleep loss.

--Mary Elizabeth Dallas

Read the original:
Sleepless Nights Do No Favors for Your Heart - Anti Aging News

Secret to reversing aging? Think again – The Korea Herald

As people age, so do their looks. In the hopes of reversing the ravages of time, a growing number of people are willing to pay for the privilege: The anti-aging industry in South Korea is expected to gross more than 28.3 trillion won ($25.1 billion) by 2020.

Yet aging is a natural process of life, and experts warn against manipulating the pace using therapies that have not yet been proven to have significant benefits.

Stem cell transfusions, a therapy used to treat failing organs, have recently become increasingly popular especially in Gangnam, an upscale area of southern Seoul. It was revealed that former President Park Geun-hye secretly received the treatment at a clinic there.

The idea is that once transplanted into the human body, stem cells differentiate into multiple body tissues, that help repair injured tissues, strengthen the structure and function of cells and produce more blood vessels.

Local beauty clinics that specialize in the use of stem cells for therapeutic purposes advertise that their treatments can help patients overcome flagging energy, poor skin elasticity and even decreased sexual desire.

Its probably overly optimistic to believe that the so-called aging-fighting treatment can reverse or slow down aging.

In fact, stem cell treatments, particularly for the use of anti-aging purposes, are not a medical field officially recognized by the Korean Medical Association, the countrys largest physicians group.

There are only seven licensed stem cell treatments worldwide, according to Chung Hyung-min, director of Stem Cell Biology School of Medicine at Konkuk University Medical Graduate School.

Stem cells are harder to operate on patients than other medicines because we have to inject cells, Chung said in an interview with a local news outlet Korea Biomedical Review, warning against the use of unproven stem cell therapies being offered across the country.

Prescribing of hormones is also widely being perceived as a therapy that help people fight aging.

The decreasing level of human growth hormones production in the bodies, which stimulate cell reproduction, leads to the acceleration of aging. So, the concept is that clinics could slow down the decrease in human growth hormone production by prescribing patients with hormones injected drugs.

Experts, however, warn that such methods, although not illegal here in practice, are not scientifically proven as increasing human growth hormones are reportedly associated with heart disease and cancer.

For Yu Byung-pal, professor emeritus of the University of Texas Health Science Center in San Antonio, aging is not a medical condition to be treated.

If there truly is a secret to slow down aging, we already have one in our body. You need a balanced, healthy diet and to consume less food on a daily basis and do regular exercise to live healthy, Yu said in his book, Live Healthy until 125.

By Bak Se-hwan (sh@heraldcorp.com)

Follow this link:
Secret to reversing aging? Think again - The Korea Herald

New Medical Geneticists Join Ted Rogers Centre for Heart Research – Newswise (press release)

Newswise TORONTO, September 6, 2017 The Ted Rogers Centre for Heart Research today announces that Dr. Raymond Kim is its newest scientific lead, guiding efforts at the countrys only clinic devoted to cardiac genomics.

The Ted Rogers Centre Cardiac Genome Clinic is Canadas first such program to investigate the genetic causes of heart failure in both children and adults. At one of the worlds only cardiac genome clinics, researchers use whole genome sequencing to help identify the cause, formulate appropriate treatment options and optimize the management of patients and family members.

Genomics is a major part of our mission to better understand the nature of heart failure in order to develop novel treatments and preventative strategies, said Dr. Mansoor Husain, executive director of the Ted Rogers Centre. We are excited to have Raymond on board to build a unique program that is set up to have a very positive impact on heart failure care across the lifespan.

Dr. Kim, one of a handful of dual-trained internal medicine and medical genetics specialists in Toronto, is a rising star in medical genetics. He holds appointments at the Division of Clinical and Metabolic Genetics at SickKids, at the Fred A. Litwin Family Centre in Genetic Medicine that is jointly run by UHN and Mount Sinai Hospital, and at the Princess Margaret Cancer Centre. His research interests include genomic medicine, rare disorder registries and weaving novel genetic technologies into patient care.

Dr. Kim will co-direct the Cardiac Genome Clinic along with fellow medical geneticist Dr. Rebekah Jobling (SickKids), who is medical geneticist in the SickKids Division of Clinical and Metabolic Genetics and molecular geneticist in its Genome Diagnostics Molecular Laboratory.

The clinic opens up the incredible opportunity for families facing cardiovascular issues to have a team of scientists search for answers in the genome, said Dr. Kim. Genome testing will gradually become a normalized part of care, and we are at the forefront of this evolution, and are already helping shape best practices in this area.The addition of unique team members like Dr. Jobling makes our team world-class.

Dr. Kim joins three other scientific leads of the Ted Rogers Centre for Heart Research: Dr. Seema Mital, Dr. Heather Ross, and Professor Craig Simmons who are respective experts in genetics, heart failure, and cell and tissue engineering. Together, they are helping direct a vast, collaborative effort to change the lives of Canadians who live with, or are at risk of, heart failure a costly disease that is a global epidemic.

ABOUT THE TED ROGERS CENTRE FOR HEART RESEARCH

The Ted Rogers Centre for Heart Research aims to develop new diagnoses, treatments and tools to prevent and individually manage heart failure Canadas fastest growing cardiac disease. Enabled by an unprecedented gift of $130 million from the Rogers family, the Centre was jointly conceived by its three partner organizations: The Hospital for Sick Children, University Health Network, and the University of Toronto. Together, they committed an additional $139 million toward the Centre representing a $270 million investment in basic science, translational and clinical research, innovation, and education in regenerative medicine, genomics, and the clinical care of children and adults. It is addressing heart failure across the lifespan. http://www.tedrogersresearch.ca / @trogersresearch

To transform the care of children and adults with heart failure through discovery, innovation and knowledge translation.

Continued here:
New Medical Geneticists Join Ted Rogers Centre for Heart Research - Newswise (press release)

Seniors enter final year of school at UMFK – WAGM

FORT KENT, Me (WAGM) "I'm so excited for my parents to have somebody in our family graduate from a University."

It's a big year for Marina Koloamatangi. The senior at the University of Maine at Fort Kent will receive a degree in behavioral science this May. Though that moment will be one she won't forget, she's also looking forward to what'll happen throughout the many months before that.

"Yeah, I was just really excited to see my friends, start playing basketball again, and work on my senior year," she said.

Koloamatangi came to Fort Kent last year as a transfer student from the Bay Area of California. The 5'11 basketball forward has her eyes set on a ring this year, but beyond that, she says this will be an important year for her in choosing her career path.

"I think I'm still kind of hesitant on what exactly I want to do but our behavioral science program has definitely guided me in the right direction on what I want to do in the future," she said.

One thing she's certain about though - this won't be the end of her schooling. She wants to get her masters in sports psychology right away.

"I just feel like if I was done here I'd probably just be limiting myself. So, yeah, I'm ready for more school," she said.

Other students of course will take a different path by jumping right into the working world. The University of Maine at Fort Kent has 475 seniors this year. University President John Short says this year for them should be all about experiential education.

"For students in nursing, getting those clinical experiences...for students in education doing student teaching, for others doing internships...it's a focus to the future, a sense of what's next in your future," said Short.

A future that this California gal couldn't be more ready for.

"It doesn't even feel like school to me. It feels like doing what I love and I'm really excited," she said.

The end of one era, can only mean the beginning of another.

Read the original here:
Seniors enter final year of school at UMFK - WAGM

Virtual Reality Can Make a Remote Crisis Real and Spur Effective Responses – University of Virginia

In Gyumri, Armenia, about 4,000 survivors of a 1988 earthquake that destroyed their city are still living in uninsulated shipping containers. Their improvised shelters are susceptible to flooding when it rains and, because of the moisture, infested with mold.

Engineers a half a world away can help solve these problems through virtual reality, according to Bethany Gordon, a first-year Ph.D. student in civil engineering at the University of Virginia.

Virtual reality can give you an understanding of someone elses world in minutes, Gordon said in a podcast that won an international competition this summer. Its not a perfect understanding, and maybe you are not aware of all the cultural nuances, but you can make that connection in five minutes by sitting on your couch and looking through a $10 virtual reality viewer.

Gordon, of Richmond, entered the contest sponsored by the Department of Science, Technology, Engineering and Public Policy at the University College London while attending the Global Grand Challenges Summit in Washington, D.C. in July. The summit was organized by the Royal Academy of Engineering and its American and Chinese counterparts, and drew hundreds of science and engineering professionals and students from across the three hosting countries.

Addressing the contests theme, How Engineers Can Change the World, Gordon offered the idea that engineers can use virtual reality to explore problems in remote areas without having to travel there.

In her podcast, Gordon also cited the work of Pablo Suarez, associate director of research and innovation at the Red Cross Red Crescent Climate Centre in the Netherlands. Suarez, who teaches at the University of Lugano, University College London and Boston University, sees the potential of virtual reality in increasing awareness of projected threats against people in the future.

Virtual reality can create a genuinely immersive experience, where your senses are exposing your mind and soul to a reality that is not your reality, Suarez said on her podcast. We call it virtual, but it can be very real and realistically convey the threat that happened from a flood that happened in Togo, downstream from a hydropower dam, all the way to the meeting of Arctic sea ice. Virtual reality offers a magical way to connect what we know with what we can do.

Gordon, who received her undergraduate degree in civil engineering from UVA in May, wants to integrate virtual reality into her research, which involves developing sustainable design interventions for civil engineers using behavioral science and neuroscience. Gordon is starting to explore the idea that increasing the blood flow to the parts of an engineers brain dealing with empathy will produce more sustainable designs. Gordon is also working on the hypothesis that the later in the process an engineer commits his or her design to a model, the more willing the engineer is to change the design.

I hope to focus specifically on sustainable development in resource-restricted communities, she said. It combines many of my passions civil engineering, neuroscience, sustainability and virtual reality. There are many practical applications for virtual reality that will emerge as it becomes more accessible the potential of an immersive, non-intrusive environment has a lot of potential.

Gordon believes that virtual reality can be used to prevent problems and save lives.

Virtual reality connects what we know with what we can do, she said, echoing Suarez. The knowledge of an engineering professional and the ability to approach problems in a systematic way can be applied to people who may be living in unhealthy situations, or struggling to survive.

She cited Rajiv J. Shah, president of the Rockefeller Foundation, who spoke at the 2017 Global Grand Challenges Summit, where he urged the audience not to be moral bystanders, but to be moral leaders to take initiative and solve the problems of those who are often forgotten.

It is our moral obligation as people who possess this knowledge to not forget about the problems of our poorest global citizens, Gordon said in the podcast. And yet it is easy for that sentiment to bleed into the background of our many other important obligations, such as work and family. Virtual reality has the potential to change that.

Gordon said she attended the Global Grand Challenges Summit to have in-depth conversations with thought leaders and other students in engineering. I wanted to exchange ideas in the hope of building potential collaborations or coming up with impactful ideas. I found myself constantly in deep thought about how the speakers wisdom related to the issues I was hoping to learn more about, she said.

Gordons podcast bested a field of 150 contestants. She and the second place-winning team, Yun Gu of Peking University in Beijing and Katie Brown of Auburn University, will receive fully funded attendance at the next Global Grand Challenges Summit in London in 2019, organized by the Royal Academy of Engineering.

It is our moral obligation as people who possess this knowledge to not forget about the problems of our poorest global citizens.

- Bethany Gordon

Gordons mentor, Leidy Klotz, an associate professor of civil and environmental engineering and architecture at UVA, praised the graduate student for her drive and creativity.

Bethany is a uniquely creative engineer who is not afraid to seek insight from other disciplines in her quest to help people, Klotz said. She combines her creativity and intelligence with an unmatched work ethic. I am so fortunate to have the opportunity to work closely with Bethany over the next few years, and I look forward to seeing the massive contributions I am sure she will continue to make in her lifes work.

A graduate of the Episcopal High School of Alexandria, Gordon plans a career in academia, teaching, mentoring and performing research that revolves around humanitarian aid, accessible sustainability and built environment design in resource-restricted communities.

See original here:
Virtual Reality Can Make a Remote Crisis Real and Spur Effective Responses - University of Virginia

Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 – GlobeNewswire (press release)

Dublin, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The "Nanobiotechnology Applications, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. It includes some of the physical forms of energy such as nanolasers. Some of the technologies are scaling down such as microfluidics to nanofluidic biochips and others are constructions from bottom up. Application in life sciences research, particularly at the cell level sets the stage for role of nanobiotechnology in healthcare in subsequent chapters.

An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug development - from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based on nanobiotechnology will enable high-throughput screening. Some of nanostructures such as fullerenes are themselves drug candidates as they allow precise grafting of active chemical groups in three-dimensional orientations. The most important pharmaceutical applications are in drug delivery. Apart from offering a solution to solubility problems, nanobiotechnology provides and intracellular delivery possibilities. Skin penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices with autonomous operation guided by the needs.

Nanomedicine is now within the realm of reality starting with nanodiagnostics and drug delivery facilitated by nanobiotechnology. Miniature devices such as nanorobots could carry out integrated diagnosis and therapy by refined and minimally invasive procedures, nanosurgery, as an alternative to crude surgery. Applications of nanobiotechnology are described according to various therapeutic systems. Nanotechnology will markedly improve the implants and tissue engineering approaches as well. Of the over 1,000 clinical trials of nanomedicines, approximately 100 are selected and tabulated in major therapeutic areas. Other applications such as for management of biological warfare injuries and poisoning are included. Contribution of nanobiotechnology to nutrition and public health such as supply of purified water are also included.

Future nanobiotechnology markets are calculated on the basis of the background markets in the areas of application and the share of this market by new technologies and state of development at any given year in the future. This is based on a comprehensive and thorough review of the current status of nanobiotechnology, research work in progress and anticipated progress. There is definite indication of large growth of the market but it will be uneven and cannot be plotted as a steady growth curve. Marketing estimates are given according to areas of application, technologies and geographical distribution starting with 2016. The largest expansion is expected between the years 2021 and 2026.

Profiles of 252 companies, out of over 500 involved in this area, are included in the last chapter along with their 183 collaborations.The report is supplemented with 51 Tables, 31 figures and 800 references to the literature.

Key Topics Covered:

Part I: Applications & Markets

1. Introduction

2. Nanotechnologies

3. Nanotechnologies for Basic Research Relevant to Medicine

4. Nanomolecular Diagnostics

5. Nanopharmaceuticals

6. Role of Nanotechnology in Biological Therapies

7. Nanodevices & Techniques for Clinical Applications

8. Nanooncology

9. Nanoneurology

10. Nanocardiology

11. Nanopulmonology

12. Nanoorthopedics

13. Nanoophthalmology

14. Nanomicrobiology

15. Miscellaneous Healthcare Applications of Nanobiotechnology

16. Nanobiotechnology and Personalized Medicine

17. Nanotoxicology

18. Ethical and Regulatory Aspects of Nanomedicine

19. Research and Future of Nanomedicine

20. Nanobiotechnology Markets

21. References

Part II: Companies

22. Nanobiotech Companies

For more information about this report visit https://www.researchandmarkets.com/research/xnnnck/nanobiotechnology

See the original post here:
Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 - GlobeNewswire (press release)

Taking Advantage Of Behavioral Economics Can Get Aid To More … – Fast Company

One of the biggest challenges that aid groups face when battling poverty in the developing world is that being in poverty can make it nearly impossible to act in your own long-term best interest. Offering someone access to a savings account that generates good interest, for instance, isnt particularly enticing to a person who is worrying about not having enough money to get through that day. Its harder for a family to save scholarship money earmarked for an upcoming school enrollment, say, when everyones stomach is rumbling.

These problems stem from two well-known psychological ticks that come with stress: present bias (favoring immediate rewards over long-term considerations) and limited attention (when lack of money, time, hunger, and/or sleep affect rationalization). Sure, the wealthy might be pressed for time, too, but they compensate by hiring more help or outsourcing chores. Poor people can end up trapped in a vicious cycle.

Once you put in that sort of extra mental effort, its often zero or close to zero marginal cost in terms of the actual execution of the policy. [Image: RadomanDurkovic/iStock]To combat this, some interventions are designed to reduce the upfront costs (in terms of money, but also time). Others can be presented at moments when the beneficiaries feel somewhat financially stable. Together, these assists toward a more stable financial future have been shown to be extremely effective, according to a recent review in the journal Behavioral Science & Policy.

The article, entitled Overcoming Behavioral Obstacles To Escaping Poverty was commissioned by the Behavioral Science and Policy Association, a group of public and private researchers, policy analysts, and aid agencies committed to exploring the potential of behavioral economics to nudge people in subtle ways that also benefit them.

In Morocco offering households assistance filling out forms for an interest-free loan for piped-in water increased program participation by 59%. [Image: RadomanDurkovic/iStock]Even considering just a couple of the most widely and thoroughly researched behavioral science principles, [they have] the potential to improve the effect of development programs and development policiesin some cases pretty dramaticallyat little or no cost, says Christopher Bryan, an assistant professor at University of Chicago Booth School of Business, who co-authored the report. Once you put in that sort of extra mental effort, its often zero or close to zero marginal cost in terms of the actual execution of the policy. (Read more examples from the report here.)

A huge stumbling block for getting assistance, for instance, is paperwork. But offering assistance that saves time and eliminates confusion, by, say, auto-populating forms ahead of time, or offering some sort of automatic enrollment could be an equally powerful incentive: In Morocco, for instance, offering households assistance filling out forms for an interest-free loan for piped-in water increased program participation by 59%.

The number of HIV patients in rural Kenya who stuck to their medical treatment regimens changed from 40% to 53% with weekly text reminders. [Image: RadomanDurkovic/iStock]Strategically timing when and where a subsidy is offered can also dramatically affect participation. To increase the rate of health insurance adoption in Tanzania, for instance, advocates have tried targeting cash-transfer points on disbursement daysthe place where people are most likely to be flush and optimisticincreasing enrollment by 20%.

To that end, some farming improvement groups have learned to approach growers about reinvesting in better seeds or fertilizers for the next year right after their current harvest. That concept, matched with a limited-time discount to take advantage of it, has proven particularly effective, notes the review. In Bogota, Columbia, the distribution of educational subsidies has shifted to be aligned more closely with when that money needs to be spent so it isnt used for other things, something that has led to higher participation rates among the neediest.

Basic reminder prompts for dire situations that can begin to feel commonplace help, too. As the report notes, the number of HIV patients in rural Kenya who stuck to their medical treatment regimens changed from 40% to 53% with weekly text reminders. Even informal reminders and rewards can be powerful: In Chile, the members of another community improved their ability to generate savings not by tracking interest rates, but by forming a self-help group, where people openly share goals and cheer progress.

For Bryan, one of the most surprising findings was how easily some life-improving changes might be implemented. When peoples attention is so heavily taxed that they simply cant devote any of it to noticing interesting things that might be useful to them, then something as simple as pointing out what seems obvious to you can be really useful.

Follow this link:
Taking Advantage Of Behavioral Economics Can Get Aid To More ... - Fast Company

10 Ways To Stay Healthy Going Into Fall With Dr. Calapai – LATF USA

With fall around the corner comes crisp and cooler weather. It also means that the body is more susceptible to colds and getting sick.

The immune system is a large collection of different cells that have a primary goal to protect your body and attack foreign organisms or matter. Keeping these natural defenses strong is very important for transitioning into the new season and involves a variety of strategies.

So, we look to the experts for advice on how to stay healthy as the cold comes in.Dr. Christopher Calapai, D.O., a New York City Osteopathic Physician board certified in family and anti-aging medicine shares his top10 ways to keep you strong for the transitioning season. Dr.Calapai's stem cell treatments have achieved remarkable results in clinical trials on patients with conditions as varied as Alzheimer's, arthritis, erectile dysfunction, frailty syndrome, heart, kidney and liver failure, lupus, MS and Parkinson's. He has worked with Mike Tyson, Mickey Rourke, Steven Seagal, and Gotham's, Donal Logue; and as a medical consultant for the New York Rangers.

1. Exercise on a daily basis:

The minimum should be a half hour of walking continuously so as to increase oxygenation to tissues as well as deliver vitamins minerals and hormones to these cells.

2. Be sure to get good deep restorative sleep:

This should be at least six hours every night. Sleep deprivation not only makes us tired, but decreases function in almost all organs.

3. Keep chemicals and preservatives out of the diet:

We should eat as organically as possible, with the diet comprised of a variety of vegetables, fruits and good protein sources.

4. Test your blood for vitamins, minerals, and hormones:

Thousands of studies over many years have described that vitamin deficiency is correlated with degenerate disease we can give me in response among many others. This test will guide you as to exactly what nutrients you're deficient in, and what you should take. There is no better test thanthis, says Dr. Calapai.

5. Do not smoke cigarettes:

This is a no brainer for most, as they contain thousands of dangerous chemicals, which can lead to a low immune system.

6. Be careful with exposure to alcohol:

This can have the variety of effects that are hurtful to the body if done in excess

7. Maintain a clean home environment:

In areas where you spend the most time, make sure that surfaces are cleaned with products that can kill germs or viruses.Use HEPA filtration systems to capture particulate matter including dust, allergens or organisms that can make you ill.

8. Wash your hands thoroughly:

Wash a few times during the day and avoid other people that have chronic infection, flu or a virus.

9. Try to minimize stress, anxiety and irritability:

Taking a break for a few minutes during a stressful day can make the stress response much less progressive.

10. Lastly, be sure to visit your doctor for routine testing and physical exam inform:

This ensures you are constantly aware of what is going on with your body.

You can connect with the doctor at: @drcalapai on Twitter or atwww.drcal.net

Read the original:
10 Ways To Stay Healthy Going Into Fall With Dr. Calapai - LATF USA

Amazing Thailand Health and Wellness Tourism Showcase 2017 promotes Kingdoms Holistic Paradise – eTurboNews

The Tourism Authority of Thailand (TAT) recently organised the4thAmazing Thailand Health and Wellness Tourism Showcasewith the theme of Thailand: Paradise for Longevity to promote the Kingdom as a destination for products and services for a longer life. The one-day event was held on 11 August, offering specialhealth and wellnessdeals until 31 December.

Mr. Noppadon Pakprot, TAT Deputy Governor for Tourism Products and Business said, This annual showcase is part of our plan to promote Thailand as a world-class destination formedical tourism. According to a report by VISA and Oxford Economics, Thailand is considered as one of Asias top medical tourism destinations. Thailand now has 58 JCI-accredited hospitals, more than any other Southeast Asian country.

During the one-day showcase, 44 health and wellness professionals across the entire range of medial disciplines attended the event to promote Thailands health and wellness products to raise international awareness. Medical tourism facilitators and travel agencies from 30 countries worldwide also discussed business deals with participating health and wellness providers.

The event highlighted why Thailand is a Paradise for Longevity and an emerging leader in the field of Functional and Regenerative Medicine. Thailand is the first and only country in Asia with hospitals specialising in Functional & Regenerative Medicine, including Better Being Hospital and Mali Interdisciplinary Hospital.

Thailand is also Asias anti-aging centre leader with 500 medical specialists in this sector, the largest number of American Academy of Anti-Aging Medicine-certified medical professionals in the region.

The Royal Thai Government has approved90-day visasfor patients and medical visitors from Cambodia, Lao PDR., Myanmar and Vietnam (CLMV) as well as from the Peoples Republic of China in a bid to boost Thailands medical tourism. This was put in place in 22 March, this year.

In addition, long-stay 10-year visas are now available for senior nationals of 14 countries including: Japan, Australia, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Sweden, Switzerland, the United Kingdom, Canada and the United States.

TAT is also partnering with Royal Orchid Plus to offer special health and wellness tourism packages until 31 December to help promote medical tourism. This includes an invitation to Royal Orchid Plus Platinum and Gold members to visit Thailand, supported by special packages from leading hospitals and clinics, for complimentary health check-ups.

Read more from the original source:
Amazing Thailand Health and Wellness Tourism Showcase 2017 promotes Kingdoms Holistic Paradise - eTurboNews

What is agnosticism? | Christian Apologetics … – carm

by Robin Schumacher

Thomas Henry Huxley was an English biologist who was nicknamed Darwins Bulldog for his staunch support of Darwins theory of evolution. Huxley is also credited with coining the term agnostic. Following in his footsteps, his grandson Julian Huxley wrote the following about when a person should assume a position of agnosticism:

I believe that one should be agnostic when belief one way or the other is [1] mere idle speculation, incapable of verification; [2] when belief is held merely to gratify desires, however deep-seated, and not because it is forced on us by evidence; and [3] when belief may be taken by others to be more firmly grounded than it really is, and so come to encourage false hopes or wrong attitudes of mind.

Huxley felt that, All our life long we are oscillating between conviction and caution, faith and agnosticism, belief and suspension of belief.

A formal definition of Huxleys agnostic term today is: a person who holds that the existence of the ultimate cause, as God, and the essential nature of things are unknown and unknowable, or that human knowledge is limited to experience.

From this description, it can be said that an agnostics position is one where he says that he does not know if God exists. Speaking more broadly, some agnostics state that it is difficult to hold any truth with certainty.

Agnosticism typically takes one of two forms--hard and soft. The hard agnostic says that a person cant know anything for sure. However, this is a self-defeating position as the hard agnostic says he knows for sure that he cant know anything for sure. Hard agnosticism simply has no container that can keep its universal solvent, and therefore it becomes an untenable position to hold and must be discarded.

In contrast to hard agnosticism, the soft agnostic says he/she doesnt know anything for sure. At issue is not the lack of human ability for knowing a particular truth, but rather the agnostic struggles with how a truth claim can be verified or shown to be true. It is the ancient pursuit of what in philosophy is called epistemology--how do we know, and how do we know that we know? When the issue of determining the existence of the Christian God is added to the mix, things get even stickier.

But perhaps that doesnt need to be the case. What if a person truly follows and applies Julian Huxleys criteria for determining when to be agnostic about a particular truth claim? What would be the end result when Huxleys measures are applied to the claims of the New Testament and specifically its account of Jesus Christ?

Huxleys first condition is that a belief cannot be mere idle speculation or be incapable of verification. This first standard seems reasonable as pure conjecture or hearsay should not be a basis for committing oneself to a belief. The second condition appears logical also and is sometimes termed the principle of falsification, which was used by philosophers such as Anthony Flew in his initial writings on religion.

How do the claims of the New Testament and Christianity hold up under Huxleys first criterion? When the legal/historical methods for determining truth are applied to the New Testament, it stands very firm under Huxleys standard.

The writers of the New Testament never state that their beliefs were based on hearsay or were events that could not be authenticated. Quite the opposite, as apostles such as Peter say, For we did not follow cleverly devised tales when we made known to you the power and coming of our Lord Jesus Christ, but we were eyewitnesses of His majesty (2 Peter 1:16). The disciples recorded occurrences that happened in actual space/time, saw these events with their own eyes, and recorded Jesus life, death, and resurrection so that others would know the truth of what happened.

In terms of falsification, the apostle Paul gave the enemies of Christianity a single truth claim that, if proven untrue, would crumble and destroy Christianity in an instant: But if there is no resurrection of the dead, not even Christ has been raised; and if Christ has not been raised, then our preaching is vain, your faith also is vain (1 Corinthians 15:1314). Paul says if the resurrection of Christ did not occur, then the Christian faith is literally empty (vain). That, Paul says, is how Christianity can be falsified: find the body of that Jewish carpenter and the Christian faith is undone.

But earlier in that same chapter, Paul actually challenges his readers of that day to go check for themselves that the tomb of Jesus was truly empty: He appeared to Cephas, then to the twelve. After that He appeared to more than five hundred brethren at one time, most of whom remain until now, but some have fallen asleep; then He appeared to James, then to all the apostles; and last of all, as to one untimely born, He appeared to me also (1 Corinthians 15:58). Paul is literally asking his readers to verify his claims with many others (over 500) alive at that time who saw Christ and could act as witnesses to validate the fact that Jesus resurrection actually occurred in space/time history.

But, given that we cannot do that today, how can modern-day people know that Paul and the other apostles were telling the truth? The apostles answer that question through their grave markers. All except John were martyred for their testimony. People may be deceived and die for a lie, but no one dies for what he knows is a lie. All the apostles had to do to save their lives was recant their testimony and say they didnt see Jesus alive, but none did. Greater evidence for believability cannot be had.

Moving on from Huxleys first criterion brings the discussion to his second and third standards, which are nearly identical in nature. Huxley says that a belief should be discarded if the sole purpose is to satisfy some psychological desire and if the belief is not well-grounded from a reality perspective thus producing false hopes in its target. This benchmark measure for a belief is certainly rational--as the only reason to believe anything is that that particular thing (truth claim) is true.

Oftentimes, the psychiatrist Sigmund Freud is quoted to show how religion fails such a test. Speaking of religious beliefs, Freud said: They are illusions, fulfillments of the oldest, strongest, and most urgent wishes of mankind. We call belief an illusion when a wish-fulfillment is a prominent factor in its motivation, and in doing so we disregard its relation to reality, just as the illusion itself sets no store by verification.

However, Freuds criteria do nothing to prove or disprove God--as his sword cuts in both directions. Could it not be true that atheists have wishes and urges of their own? Perhaps it's a wish that a God who will call them to account one day for their actions does not exist. Such a desire can be very motivating and drive a person to hold an atheistic position. So in reality, Freuds words have no power whatsoever to determine if the truth claims of Christianity are valid or not.

Freuds thoughts aside, how does the New Testament stand up against Huxleys second and third standards? As it does with Huxleys first measure, the New Testament does extremely well.

First, from a legal/historical perspective, no document from antiquity comes even close to the New Testament where passing the general criteria for judging the validity of a historical work is concerned. The New Testament passes the bibliographical test (manuscript reliability and early dating), internal-evidence test (multiple-key testimonies all of which match), and the external-evidence test (outside evidence that corroborates the documents testimony) with flying colors.

Second, as many have said, the New Testament is not written like a lie. The New Testament writers would not have invented accounts, such as Jesus being buried by a member of the Sanhedrin, women being the first witnesses of Christs resurrection, and other such things.

Rather, what is found is a strong commitment to accuracy no matter where the evidence led them. Such dedication is seen in the pen of Luke: Inasmuch as many have undertaken to compile an account of the things accomplished among us, just as they were handed down to us by those who from the beginning were eyewitnesses and servants of the word, it seemed fitting for me as well, having investigated everything carefully from the beginning, to write it out for you in consecutive order, most excellent Theophilus; so that you may know the exact truth about the things you have been taught (Luke 1:14).

Lastly, as has already been pointed out, the New Testament writers died for their testimony. As theologian and professor Peter Kreeft points out: Why would the apostles lie? . . . If they lied, what was their motive . . .? What they got out of it was misunderstanding, rejection, persecution, torture, and martyrdom. Hardly a list of perks!

The treatment Kreeft lists certainly is not desirable from a psychological perspective and would produce no false hopes in the disciples as they would obviously know their claims were false if they were lying. Adding this to arguments above, we see that the New Testament accounts overcome Huxleys second and third hurdles for being agnostic.

In the end, a person who claims to be agnostic about Christianity but uses Julian Huxleys own criteria for determining whether one should be agnostic will have to seriously reconsider his position. With the hard agnostic position being ruled out as self-defeating and the soft agnostic position being challenged by the compelling evidence of the New Testament, the more reasonable conclusion for the agnostic to reach, once everything has been examined, seems to be that Christianity is true.

Read more:
What is agnosticism? | Christian Apologetics ... - carm

Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report – MENAFN.COM

(MENAFN Editorial) iCrowdNewswire - Sep 4, 2017

The Global Nanomedicine Market 2017 Industry Research Report' report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the Global major industry players in detail.

The Global Nanomedicine Market Research Report 2017 renders deep perception of the key regional market status of the Nanomedicine Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, #China and Japan.

Complete report on Nanomedicine market report spread across 116 pages, profiling 12 companies and supported with tables and figuresavailable @

The report on 'Global Nanomedicine Market is a professional report which provides thorough knowledge along with complete information pertaining to the Nanomedicine industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc.

The potential of this industry segment has been rigorously investigated in conjunction with primary market challenges. The present market condition and future prospects of the segment has also been examined. Moreover, key strategies in the market that includes product developments, partnerships, mergers and acquisitions, etc., are discussed. Besides, upstream raw materials and equipment and downstream demand analysis is also conducted.

Report Includes:-

The report cloaks the market analysis and projection of 'Nanomedicine Market on a regional as well as global level. The report constitutes qualitative and quantitative valuation by industry analysts, first-hand data, assistance from industry experts along with their most recent verbatim and each industry manufacturers via the market value chain. The research experts have additionally assessed the in general sales and revenue generation of this particular market. In addition, this report also delivers widespread analysis of root market trends, several governing elements and macro-economic indicators, coupled with market improvements as per every segment.

For any Inquire before buying @

Global Nanomedicine market competition by top manufacturers/players, with Nanomedicine sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., SigmaTau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A

The report is generically segmented into six parts and every part aims on the overview of the Nanomedicine industry, present condition of the market, feasibleness of the investment along with several strategies and policies. Apart from the definition and classification, the report also discusses the analysis of import and export and describes a comparison of the market that is focused on the trends and development. Along with entire framework in addition to in-depth details, one can prepare and stay ahead of the competitors across the targeted locations. The fact that this market report renders details about the major market players along with their product development and current trends proves to be very beneficial for fresh entrants to comprehend and recognize the industry in an improved manner. The report also enlightens the productions, sales, supply, market condition, demand, growth, and forecast of the Nanomedicine industry in the global markets.

Buy a copy of this report @

Every region's market has been studied thoroughly in this report which deals with the precise information pertaining to the Marketing Channels and novel project investments so that the new entrants as well as the established market players conduct intricate research of trends and analysis in these regional markets. Acknowledging the status of the environment and products' up gradation, the market report foretells each and every detail.So as to fabricate this report, complete key details, strategies and variables are examined so that entire useful information is amalgamated together for the understanding and studying the key facts pertaining the global Nanomedicine Industry. The production value and market share in conjunction with the SWOT analysis everything is integrated in this report.

Table of Contents

1 Nanomedicine Market Overview 2 Global Nanomedicine Market Competition by Manufacturers 3 Global Nanomedicine Capacity, Production, Revenue (Value) by Region (2011-2016) 4 Global Nanomedicine Supply (Production), Consumption, Export, Import by Regions (2011-2016) 5 Global Nanomedicine Production, Revenue (Value), Price Trend by Type 6 Global Nanomedicine Market Analysis by Application 7 Global Nanomedicine Manufacturers Profiles/Analysis

8 Nanomedicine Manufacturing Cost Analysis 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 11 Market Effect Factors Analysis 12 Global Nanomedicine Market Forecast (2016-2021) 13 Research Findings and Conclusion

About Us

Deep Research Reportsis digital database of syndicated market reports for global and #China industries. These reports offer competitive intelligence data for companies in varied market segments and for decision makers at multiple levels in these organizations. We provide 24/7 online and offline support to our customers.

Connect us

Hrishikesh Patwardhan

Corporate Headquarters

2nd floor, metropole,

Next to inox theatre,

Bund garden road,Pune-411001.

1 888 391 5441

MENAFN0509201700703403ID1095819074

Read more here:
Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report - MENAFN.COM

New class of drugs targets aging to help keep you healthy – CNN

Story highlights

"This is one of the most exciting fields in all of medicine or science at the moment," said Dr. James Kirkland, director of the Kogod Center on Aging at the Mayo Clinic and lead author of the new paper.

Senescent cells play a role in many age-related chronic diseases, such as diabetes, cardiovascular disease, most cancers, dementia, arthritis, osteoporosis and blindness, Kirkland said. Therefore, senolytic drugs are a possible treatment approach for such diseases.

As a practicing physician, Kirkland said that he has grown increasingly concerned for his patients who are sick with many of these age-related conditions.

"The same processes that cause aging seem to be the root causes of age-related diseases," he said. "Why not target the root cause of all of these things? That would have been a pipe dream until a few years back."

Fourteen senolytic drugs have been discovered and are being actively studied, 11 of which Kirkland's colleagues and their collaborators found, he said.

Are these age-modifying drugs ready for human trials?

Scientists have long known that certain processes influence your body's aging on the cellular level, according to the paper. Those processes include inflammation, changes in your DNA, cell damage or dysfunction and the accumulation of senescent cells.

It turns out that those processes are linked. For instance, DNA damage causes increased senescent cell accumulation, Kirkland said.

So an intervention that targets senescent cells could attenuate other aging processes as well, according to the new paper. That is, once such an intervention is tested for efficacy and safety.

"I think senolytic drugs have a great future. If it is proven that it can reduce senescent cells and rejuvenate tissues or organs, it may be one of our potential best treatments for age-related diseases," said Dr. Kang Zhang, founding director of the Institute for Genomic Medicine at the University of California, San Diego, who was not involved in the new paper.

Yet taking senolytic drugs from mouse studies to human ones is a "big leap," Zhang said.

"So we will have to wait for clinical trials to see whether this would work in humans," he said. "One possible clinical trial strategy is to test this class of drugs in an age-related disease, such as neurodegeneration, like Parkinson's disease, to see if it can reduce clinical severity of the disease and improve tissue functions."

In the new paper, the researchers wrote that potential clinical trial scenarios include testing whether senolytic drugs could alleviate multiple chronic diseases in a single patient or whether such drugs could treat conditions that involve senescent cell accumulation in one location in the body, such as osteoarthritis.

Other potential clinical trial scenarios include testing whether the drugs could alleviate frailty in older adults or could treat conditions associated with chemotherapy or radiotherapy, since radiation can produce cellular senescence, Kirkland said.

For instance, "in mice, if you treat one leg with enough radiation, after three months, the mouse has trouble walking. If you give a single dose of these drugs, they're able to walk quite well, and that persists for two years," he said. "These drugs could mitigate the effects of therapeutic radiation."

"Some of the drugs at the moment are moderately expensive," he said.

"If we're able to reduce hospitalizations ... the savings on the medical care and hospital side might more than offset the cost of these drugs by a longshot," Kirkland said, though it remains unclear what the dosage options would be for senolytic drugs for short- or long-term use.

As for how soon he thinks human clinical trials might commence, Kirkland said doctors could have an idea of how well senolytic drugs work for serious health conditions in about a year and a half or two years.

Once the drugs are tested in humans, researchers expect many companies to be lining up to develop or manufacture senolytic drugs. Some have already expressed interest.

"In the coming decades, I believe that health care will be transformed by this class of medicine and a whole set of diseases that your parents and grandparents have will be things you only see in movies or read in books, things like age-associated arthritis," said David, whose company was not involved in the new paper.

Yet he cautioned that, while many more studies may be on the horizon for senolytic drugs, some might not be successful.

"One thing that people tend to do is, they tend to overestimate things in the short run but then underestimate things in the long run, and I think that, like many fields, this suffers from that as well," David said.

"It will take a while," he said. "I think it's important to recognize that a drug discovery is among the most important of all human activities ... but it takes time, and there must be a recognition of that, and it takes patience."

View original post here:
New class of drugs targets aging to help keep you healthy - CNN

Nutrition Education Professional (id:43168) – Bangor Daily News

Select a major from the list

Accounting

Acting

Actuarial Science

Advertising

Aeronautical and Astronautical Engineering

Aerospace Engineering

African-American Studies

Agricultural Business

Agricultural Sciences

Agriculture and Food Security

Agriculture Production

Air Transportation and Distribution

Alternative Medicine

American Literature

American Sign Language - ASL

American Studies

Animal Science

Animal Services

Anthropology / Archeology

Applied / Commercial Art

Applied Mathematics

Applied Sciences

Architectural History

Architectural Technology

Architecture

Art History

Arts

Asian Studies

Astronomy / Astrophysics

Atmospheric Science

Banking

Biblical Studies

Biochemistry

BioEngineering

Bioinformatics

Biological and Agricultural Engineering

Biology / Biological Sciences

Biomedical and Medical Engineering

Biomedical Sciences

Biophysics

Biotechnology

Bookkeeping

Botany

Business Administration

Business Economics

Business Finance

Business Management

Business Marketing

Cellular Biology and Anatomical Sciences

Ceramic Engineering

Chemical Engineering

Chemistry Sciences

Child Care / Child Psychology

Chinese

Chinese Studies

Chiropractics

Civil Engineering

Classical Studies

Clinical Laboratory Science Professions

Clinical Psychology

Communication Disorders Sciences

Communication Studies

Communication Technology

Comparative Language Studies and Services

Computational Finance

Computer and Information Sciences

Computer Engineering

Computer Programming

Computer Systems Analysis

Construction

Corporate Strategy

Cosmetology and Related Services

Counseling and Guidance

Creative Writing

Criminal Justice, Law Enforcement, and Corrections

Criminology

Culinary Arts and Culinary Services

Cultural Studies

Curriculum and Instruction

Dance

Data Entry Processing

Decision Sciences

Dentistry

Design and Applied Arts

Developmental Psychology

Digital, Radio, and Television Communication

Drafting and Design Engineering

Drama

Earth Science

Ecology and Evolutionary Biology

Economics

Education

Educational Administration and Supervision

Educational Evaluation and Research

Electrical Engineering

Electrical Repair and Maintenance

Electronic Communication System Technology

Electronics

Engineering - Architectural

See more here:
Nutrition Education Professional (id:43168) - Bangor Daily News

Singing May Be Good Medicine for Parkinson's Patients – Anti Aging News

Sometimes modern medicine and miracle drugs are the answer. Sometimes the remedies simply require a much more common sense approach. Obviously, singing requires muscle and breathing control. It helps exercise and strengthen muscles that arent used during regular conversation. Since all of these functions are affected negatively by Parkinsons Disease, it only makes sense that singing, a fun activity, would help those with this horrible disease, Editor,www.WorldHealth.net.

(HealthDayNews) -- Singing? To benefit people with Parkinson's disease? It just may help, a researcher says.

"We're not trying to make them better singers, but to help them strengthen the muscles that control swallowing and respiratory function," said Elizabeth Stegemoller, an assistant professor of kinesiology at Iowa State University.

Stegemoller holds a weekly singing therapy class for Parkinson's disease patients. At each session, participants go through a series of vocal exercises and songs.

Singing uses the same muscles as swallowing and breathing control, two functions affected by Parkinson's disease. Singing significantly improves this muscle activity, according to Stegemoller's research.

"We work on proper breath support, posture and how we use the muscles involved with the vocal cords, which requires them to intricately coordinate good, strong muscle activity," she said in a university news release.

Other benefits noted by patients, their families and caregivers include improvements in mood, stress and depression, Stegemoller said.

Her research was published inComplementary Therapies in Medicine.

Parkinson's disease is a chronic and progressive movement disorder. Nearly one million Americans live with the disease. The cause isn't known, and there is no cure at present. But there are treatment options such as medication and surgery to manage symptoms, according to the Parkinson's Disease Foundation.

Symptoms can include tremors of the hands, arms, legs, jaw and face; slowness of movement; limb rigidity; and problems with balance and coordination.

More:
Singing May Be Good Medicine for Parkinson's Patients - Anti Aging News

New Study Shows Gut Bacteria Produces Secret, Anti-Aging Molecules – Wall Street Pit

When we were young, we viewed our parents like they were the most powerful human beings in the world.

They exuded health, strength, such admirable quickness of mind in answering our endless questions, and the might to balance career and family.

How did they do it?

That used to puzzle us, as we kept getting delighted in the thought that we had extraordinary human beings playing the role of mom and dad.

At first, we begin to blame our society or the world in general for the wealth of new and challenging problems that people are forced to face everyday. Then, gradually we begin to realize that life for our parents after all, wasnt as easy as we had perceived it when we were young.

As the years go by, with us having our own families, and going through the same stressful phases that our parents had gone through, its right then we start to realize that the weaknesses and diseases that came to plague our mom and dad would also be our unavoidable fate.

Were all destined to grow old.

Today, the global anti-aging industry is worth more than $140 billion and has been predicted to rise to nearly $217 billion by 2021.

The worlds leading companies, including Google, are involved in anti-aging research and treatment of age-related diseases.

From Senescence Info, heres a list of some of these companies and their anti-aging endeavors:

Now, whats new?

The discovery, this time, is not about yeast, telomeres, stem cells, or genes.

Its about molecules. To be exact, a molecule type thats produced by commensal bacteria and one which has the ability to extend healthspan.

Commensal bacteria are living organisms that derive their food from other living organisms. But, unlike parasites, they do not harm or hurt their host. This type of bacteria, also known as commensal microflora, usually inhabit the gut, respiratory tract, and skin.

In humans, the number of commensal bacteria that colonize our skin and mucosal surfaces is greater than the number of cells forming our body.

However, this molecule called indole, which was discovered by researchers at the Emory University School of Medicine, came from commensal bacteria that the team studied in the gut of worms (Caenorhabditis elegans), mice, and fruit flies to determine its anti-aging properties.

According to the authors, and as published on PNAS, the small molecules [which are shown to be] produced by the microbiota and related to indole extend healthspan in geriatric worms, flies, and mice, without attendant effects on lifespan. Indoles act via the aryl hydrocarbon receptor (AHR) and cause animals to retain a youthful gene expression profile. Indoles may represent a new class of therapeutics that improve the way we age as opposed to simply extending how long we live.

Indoles and AHR are also found in the human body. The former exists in humans and mammals in small quantities, produced from plant dietary sources and intestinal microbiota. Whats more fascinating about indole is that it can extend not only an organisms healthspan, but fecundity and reproductive span as well.

The study is statistically extremely robust, remarks Dario Valenzano of the Max Planck Institute for Biology of Ageing. The paper convincingly shows that the lack of indoles is detrimental to healthspan. What will be interesting is to see if the same effect holds good with wild-type animals treated [extraneously] with indoles.

Indeed, its a remarkable discovery. But, mankind appears to unfortunately, still have a long way to go in their quest for longer, healthier life.

As study author Daniel Kalman notes: It is a long road to go from the data we present to a drug. That takes careful development, testing, and safety and efficacy trials.

Despite the relatively long road ahead (I say relatively based on the fact that AI applications are on a seemingly rapid upward trajectory and anything is possible. We may have a breakthrough tomorrow or five years from, nobody knows for sure) the fact that new advancements in modern technology are finally offering up some real promising possibilities for ways to reverse aging as a process, is a breakthrough in anti-aging research and the right step toward a healthier, longer life and consequently, a brighter future for all of us.

Visit link:
New Study Shows Gut Bacteria Produces Secret, Anti-Aging Molecules - Wall Street Pit

SRU completes busy summer of campus improvements – Allied News

SLIPPERY ROCK - While students returning to Slippery Rock University for the fall semester may have noticed a few physical changes to the campus exterior, the most visible changes have occurred on building interiors and student's computer screens.

The most noticeable of all exterior changes that occurred over the summer was the demolition of the former Kraus Hall. Built in 1966, the hall, located on Main Street, was originally known as "The Riviera," a privately owned facility belonging to Stanley Kraus. Kraus donated the hall to the University in 1982. The hall, valued at $4.5 million at that time, was the largest gift ever received by the University. It continued to house students until 2009. It was demolished at a cost of approximately $150,000.

The now empty lot will be used as a staging area for materials and trailers when the renovation projects for SRU's performing arts buildings - Miller Auditorium, East Gym and West Gym - begin later this year. Long-term plans for the former Kraus Hall space are undetermined.

Projects that either started during the summer or were scheduled to start, including a $6.5 million renovation to the Strain Behavioral Science Building, will continue during the fall. However, according to Scott Albert, assistant vice president of facilities, planning and environmental safety, the value of completed improvements on campus during the summer was estimated at $6 million.

"It was one of our busiest summers because of the timing of projects," Albert said. "Overall, if you look at the volume of construction that's been ongoing, year to date and, with the BSB and performing arts projects kicking off, it'll be close to one of our busiest overall years in the past 20 years."

The first phase of a $4 million improvement project for Bailey Library was completed during the summer, which included the renovation of the second and third floor restrooms that were closed during the summer. Ongoing improvements, which will continue through the fall, include an additional computer lab and study spaces, a redesigned entryway and an expanded caf. The project is scheduled for completion in December.

"From a cost perspective, Bailey was the biggest project of the summer," Albert said. "When all the projects are completed, it'll provide an exciting and modern look to the campus. Until then, we appreciate everyone's patience."

Other significant changes from the summer included second floor renovations to Rhoads Hall; improved accessibility to the Gail Rose Lodge; the replacement of the Swope Music Hall loading dock; and asphalt maintenance and seal coating to several parking lots. An underground condensate line, that returns water from the McKay Education Building to the boiler plant, was also replaced. Restoration work from that project continues near Old Main.

There were also considerable upgrades related to classrooms, technology and sustainability:

Students may notice changes in lighting, as the University continues to switch completely over to LED lighting, which uses less energy and lasts longer.

Eight classrooms were upgraded with new technology, including items such as laser projectors and digital audio controls. The upgraded classrooms included two each in the Eisenberg Classroom Building, the School of Physical Therapy Building, Spotts World Culture Building and the Advanced Technology and Science Hall. A "Concepts of Sciences Lab" was created in Room 130 of ATSH while Room 103 of Spotts was converted from a classroom to a computer lab.

More than 700 computers were replaced in academic buildings, making this year one the largest-scale overhauls in recent years as most computers are replaced on a three-year cycle.

As part of yearlong upgrades, 350 Wi-Fi access points were replaced in various academic buildings and the Smith Student Center that will give students stronger connections with more bandwidth. An additional 250 access points are scheduled to be replaced in other campus buildings this academic year.

See a gallery of photos at: http://www.sru.edu/news/083117a

Continue reading here:
SRU completes busy summer of campus improvements - Allied News